For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Renal Sympathetic Denervation | Catheter-based Renal Sympathetic Denervation Ablation Arm Renal sympathetic denervation: • The ablation catheter is placed within a long vascular sheath and advanced into the renal artery. The sheath is advanced over the catheter to engage the renal artery ostium and allow for contrast injection and visualization of the vessel during catheter manipulation. • After completion of the measurement, no more than six radiofrequency ablation lesions separated both longitudinally and rotationally (a "spiral pattern", see figure) will be placed per renal artery. The power will be started at 10 W and titrated to a maximum 20 W, as deemed appropriate by the impedance drop (goal 10% drop). Each lesion should be between 30-120 seconds in duration (no more than 120 seconds per lesion). | 0 | None | 3 | 9 | 5 | 9 | View |
| VT Ablation Alone | No further therapy in addition to VT ablation VT ablation alone: Placebo arm will receive standard VT ablation using current techniques | 0 | None | 2 | 8 | 3 | 8 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Macrohematuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| VT recurrence | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Non-sustained VT | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Pneumonia | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| AF with urosepsis | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Worsening heart failure/Total artifical heart implant | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Pseudoaneurysm at septal aspect of LV apex | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Dissection of left external iliac artery | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Paresthesia | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| LUE Cephalic vein thrombosis | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Hypotension with pleuritic chest pain | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Kidney pain with near syncope | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Flu | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Bradycardia associated with dyspnea on exertion | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Jaw pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| VT recurrence | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |